Coya Therapeutics Reports Additional Proof-of-Concept Clinical Biomarker Data in Patients with Alzheimers Disease
COYA Stock | 6.09 0.05 0.83% |
About 50% of Coya Therapeutics,'s investors are presently thinking to get in. The analysis of overall sentiment of trading Coya Therapeutics, Common stock suggests that some investors are interested at this time. The current market sentiment, together with Coya Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Coya Therapeutics, Common stock news signals to limit their universe of possible portfolio assets.
Coya |
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing multiple therapeutic platforms int
Read at businesswire.com
Coya Therapeutics, Fundamental Analysis
We analyze Coya Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coya Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coya Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Coya Therapeutics, is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Coya Therapeutics, Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics, stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics, could also be used in its relative valuation, which is a method of valuing Coya Therapeutics, by comparing valuation metrics with similar companies.
Peers
Coya Therapeutics, Related Equities
LTRN | Lantern Pharma | 20.06 | ||||
GANX | Gain Therapeutics | 15.72 | ||||
STRO | Sutro Biopharma | 2.90 | ||||
CUE | Cue Biopharma | 1.94 | ||||
CNTA | Centessa Pharmaceuticals | 1.92 | ||||
OPT | Opthea | 1.11 | ||||
HLVX | Hillevax | 0.52 | ||||
ELYM | Eliem Therapeutics | 0.31 | ||||
DAWN | Day One | 2.46 | ||||
CGTX | Cognition Therapeutics | 2.56 | ||||
TFFP | Tff Pharmaceuticals | 3.13 | ||||
DRMA | Dermata Therapeutics | 3.97 | ||||
TCRX | Tscan Therapeutics | 5.39 | ||||
FENC | Fennec Pharmaceuticals | 5.77 | ||||
ABOS | Acumen Pharmaceuticals | 6.19 | ||||
INAB | In8bio | 6.25 | ||||
INZY | Inozyme Pharma | 7.81 | ||||
TERN | Terns Pharmaceuticals | 9.04 | ||||
NAMSW | NewAmsterdam Pharma | 14.53 |
Complementary Tools for Coya Stock analysis
When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |